vs
Braemar Hotels & Resorts Inc.（BHR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Braemar Hotels & Resorts Inc.的1.2倍（$197.9M vs $165.6M），REPLIGEN CORP净利率更高（6.7% vs -20.3%，领先27.0%），REPLIGEN CORP同比增速更快（13.6% vs -4.5%），REPLIGEN CORP自由现金流更多（$17.6M vs $-37.1M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -13.1%）
Braemar Hotels & Resorts Inc.是一家主打高端奢华酒店及度假村持有运营的房地产投资信托，主要布局美国市场，服务高端休闲旅客、企业活动主办方及商务差旅群体，通过住宿预订、配套消费及活动承办获得收益。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BHR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$165.6M
营收增速更快
RGEN
高出18.1%
-4.5%
净利率更高
RGEN
高出27.0%
-20.3%
自由现金流更多
RGEN
多$54.7M
$-37.1M
两年增速更快
RGEN
近两年复合增速
-13.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $165.6M | $197.9M |
| 净利润 | $-33.6M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -7.3% | 9.0% |
| 净利率 | -20.3% | 6.7% |
| 营收同比 | -4.5% | 13.6% |
| 净利润同比 | -80.1% | 143.9% |
| 每股收益（稀释后） | $-0.67 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHRRGEN
| Q4 25 | $165.6M | $197.9M | ||
| Q3 25 | $143.6M | $188.8M | ||
| Q2 25 | $179.1M | $182.4M | ||
| Q1 25 | $215.8M | $169.2M | ||
| Q4 24 | $173.3M | $174.1M | ||
| Q3 24 | $148.4M | $154.9M | ||
| Q2 24 | $187.6M | $154.1M | ||
| Q1 24 | $219.1M | $151.3M |
净利润BHRRGEN
| Q4 25 | $-33.6M | $13.3M | ||
| Q3 25 | $5.7M | $14.9M | ||
| Q2 25 | $-5.5M | $14.9M | ||
| Q1 25 | $11.0M | $5.8M | ||
| Q4 24 | $-18.7M | $-30.3M | ||
| Q3 24 | $12.6M | $-654.0K | ||
| Q2 24 | $-11.6M | $3.3M | ||
| Q1 24 | $15.9M | $2.1M |
毛利率BHRRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率BHRRGEN
| Q4 25 | -7.3% | 9.0% | ||
| Q3 25 | 20.8% | 8.9% | ||
| Q2 25 | 10.0% | 7.6% | ||
| Q1 25 | 17.0% | 3.9% | ||
| Q4 24 | 2.2% | -17.7% | ||
| Q3 24 | 47.4% | -5.1% | ||
| Q2 24 | 6.5% | 1.0% | ||
| Q1 24 | 19.4% | 1.3% |
净利率BHRRGEN
| Q4 25 | -20.3% | 6.7% | ||
| Q3 25 | 4.0% | 7.9% | ||
| Q2 25 | -3.1% | 8.2% | ||
| Q1 25 | 5.1% | 3.4% | ||
| Q4 24 | -10.8% | -17.4% | ||
| Q3 24 | 8.5% | -0.4% | ||
| Q2 24 | -6.2% | 2.2% | ||
| Q1 24 | 7.3% | 1.4% |
每股收益（稀释后）BHRRGEN
| Q4 25 | $-0.67 | $0.24 | ||
| Q3 25 | $-0.12 | $0.26 | ||
| Q2 25 | $-0.24 | $0.26 | ||
| Q1 25 | $-0.04 | $0.10 | ||
| Q4 24 | $-0.47 | $-0.55 | ||
| Q3 24 | $-0.02 | $-0.01 | ||
| Q2 24 | $-0.33 | $0.06 | ||
| Q1 24 | $0.05 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $124.4M | $767.6M |
| 总债务越低越好 | $1.1B | $542.2M |
| 股东权益账面价值 | $138.7M | $2.1B |
| 总资产 | $1.9B | $2.9B |
| 负债/权益比越低杠杆越低 | 7.96× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BHRRGEN
| Q4 25 | $124.4M | $767.6M | ||
| Q3 25 | $116.3M | $748.7M | ||
| Q2 25 | $80.2M | $708.9M | ||
| Q1 25 | $81.7M | $697.2M | ||
| Q4 24 | $135.5M | $757.4M | ||
| Q3 24 | $168.7M | $784.0M | ||
| Q2 24 | $114.6M | $809.1M | ||
| Q1 24 | $137.1M | $780.6M |
总债务BHRRGEN
| Q4 25 | $1.1B | $542.2M | ||
| Q3 25 | $1.2B | $537.9M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | $525.6M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.2B | — |
股东权益BHRRGEN
| Q4 25 | $138.7M | $2.1B | ||
| Q3 25 | $211.9M | $2.1B | ||
| Q2 25 | $225.1M | $2.1B | ||
| Q1 25 | $238.9M | $2.0B | ||
| Q4 24 | $240.7M | $2.0B | ||
| Q3 24 | $276.9M | $2.0B | ||
| Q2 24 | $282.3M | $2.0B | ||
| Q1 24 | $307.3M | $2.0B |
总资产BHRRGEN
| Q4 25 | $1.9B | $2.9B | ||
| Q3 25 | $2.0B | $2.9B | ||
| Q2 25 | $2.1B | $2.9B | ||
| Q1 25 | $2.1B | $2.9B | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.2B | $2.8B | ||
| Q2 24 | $2.2B | $2.9B | ||
| Q1 24 | $2.3B | $2.8B |
负债/权益比BHRRGEN
| Q4 25 | 7.96× | 0.26× | ||
| Q3 25 | 5.50× | 0.26× | ||
| Q2 25 | 5.38× | — | ||
| Q1 25 | 5.03× | — | ||
| Q4 24 | 5.03× | 0.27× | ||
| Q3 24 | 4.36× | — | ||
| Q2 24 | 4.00× | — | ||
| Q1 24 | 3.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-37.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -22.4% | 8.9% |
| 资本支出强度资本支出/营收 | 47.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-59.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BHRRGEN
| Q4 25 | $40.8M | $25.7M | ||
| Q3 25 | $-5.8M | $48.1M | ||
| Q2 25 | $23.0M | $28.6M | ||
| Q1 25 | $15.1M | $15.0M | ||
| Q4 24 | $66.8M | $39.2M | ||
| Q3 24 | $9.0K | $49.3M | ||
| Q2 24 | $24.1M | $42.2M | ||
| Q1 24 | $36.0M | $44.7M |
自由现金流BHRRGEN
| Q4 25 | $-37.1M | $17.6M | ||
| Q3 25 | $-27.3M | $43.4M | ||
| Q2 25 | $5.3M | $21.5M | ||
| Q1 25 | $-159.0K | $11.4M | ||
| Q4 24 | $-3.8M | $33.6M | ||
| Q3 24 | $-15.6M | $42.3M | ||
| Q2 24 | $8.2M | $37.4M | ||
| Q1 24 | $12.7M | $36.4M |
自由现金流率BHRRGEN
| Q4 25 | -22.4% | 8.9% | ||
| Q3 25 | -19.0% | 23.0% | ||
| Q2 25 | 3.0% | 11.8% | ||
| Q1 25 | -0.1% | 6.8% | ||
| Q4 24 | -2.2% | 19.3% | ||
| Q3 24 | -10.5% | 27.3% | ||
| Q2 24 | 4.4% | 24.3% | ||
| Q1 24 | 5.8% | 24.0% |
资本支出强度BHRRGEN
| Q4 25 | 47.1% | 4.1% | ||
| Q3 25 | 15.0% | 2.5% | ||
| Q2 25 | 9.9% | 3.9% | ||
| Q1 25 | 7.1% | 2.1% | ||
| Q4 24 | 40.7% | 3.2% | ||
| Q3 24 | 10.5% | 4.5% | ||
| Q2 24 | 8.5% | 3.1% | ||
| Q1 24 | 10.7% | 5.5% |
现金转化率BHRRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | -1.00× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 1.38× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 2.26× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BHR
| Occupancy | $97.4M | 59% |
| Food And Beverage | $45.5M | 28% |
| Hotel Other | $22.6M | 14% |
RGEN
暂无分部数据
